Complement-targeted therapeutics

(a) The complement cascade after activation by pathogens. In addition to a low level of constant activation by the alternative pathway (AP; tick-over via hydrolyzed C3 (C3w) results in the formation of the initial C3 convertase C3wBb), the complement cascade is usually activated by antibody complexes (classical pathway) or high-density mannose (lectin pathway) on the surface of pathogens. This activation leads to the formation of the C3 convertases C4bC2a and C3wBb, which cleave native C3 to C3b and C3a. Deposition of C3b on cell surfaces via its thioester group initiates the cleavage of more C3 (the amplification loop via the final AP C3 convertase C3bBb), opsonization and phagocytosis, as well as lysis as a result of the formation of the membrane attack complex (MAC). In addition, the anaphylatoxins C3a and C5a are released and trigger further immune reactions upon binding to their receptors (C3aR, C5aR, C5L2). These combined actions of complement lead to the elimination of pathogenic cells. Recently, studies have shown that some steps of the cascade can be directly initiated by certain proteolytic enzymes (the extrinsic protease pathway) or by MBL/MASP (the C2 bypass pathway). Furthermore, the regulatory protein properdin may propagate and stabilize the formation of C3 convertases on the surface of the cell. Protein conversions are shown as black arrows and enzymatic reactions as green arrows. (b) Regulation, deactivation and inhibition of the complement cascade on host cells by natural regulators and complement-specific therapeutics. Several pathogenic processes and diseases are the result of an erroneous activation or insufficient downregulation of the complement cascade. Under normal conditions, any host-associated C3 convertase (C3bBb) undergoes an accelerated decay mediated by complement receptor 1 (CR1), decay accelerating factor (DAF), C4b-binding protein (C4BP) or factor H (fH). C3b is degraded to inactive iC3b by factor I in a reaction that requires as cofactor CR1, fH, C4BP or membrane cofactor protein (MCP). In addition, CD59 prevents the formation of the MAC. Some of the therapeutic interventions focus on increasing this downregulation by using soluble forms of these regulators (that is, sCR1, sDAF, sMCP, sCD59). Other approaches involve the substitution of the natural C1 inhibitor (C1-INH), the inhibition of the central conversion of C3 to C3b and C3a (compstatin), blockage of C5 or C5a by antibodies, and the suppression of anaphylatoxic signaling by C5a receptor antagonists. For clarity, only the regulation of the alternative pathway, which may contribute up to ~80% of all complement activity, is shown here. The C3 convertase of the classical pathway (C4bC2a), as well as the C5 convertases (C4bC2aC3b and C3bC3bBb), can be modulated by the same regulators and drug compounds. Therapeutic modulators in clinical trials or late preclinical development are indicated in red, with the circled letter referring to the corresponding drug class in and and the main text.
Complement-targeted therapeutics

Publication

Complement-targeted therapeutics. () Daniel Ricklin, et al. Nat Biotechnol. ;25(11):1265-1275. Figure: F2.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates C3 C3 ncbigene_symbol C3 718
Homo sapiens Primates C2 C2 ncbigene_symbol C2 717
Homo sapiens Primates CP CP ncbigene_symbol CP 1356
Homo sapiens Primates C4b C4B ncbigene_symbol C4B 721
Homo sapiens Primates C4a C4A ncbigene_symbol C4A 720
Homo sapiens Primates C2b C2B ncbigene_synonym SCGB2B3P 100130342
Homo sapiens Primates C3AR C3AR ncbigene_synonym C3AR1 719
Homo sapiens Primates Cis CIS ncbigene_synonym CISH 1154
Homo sapiens Primates C3b C3B ncbigene_synonym ERVK-3 100862689
Homo sapiens Primates C1a C1A ncbigene_synonym ERVK-1 100862690
Homo sapiens Primates MASP MASP ncbigene_synonym MASP1 5648
Homo sapiens Primates Ab AB ncbigene_synonym APP 351
Homo sapiens Primates Ab AB ncbigene_synonym SUCLA2 8803
Homo sapiens Primates MBL MBL ncbigene_synonym MBL2 4153
Homo sapiens Primates MBL MBL ncbigene_synonym MBL3P 50639
Homo sapiens Primates protease PROTEASE ncbigene_synonym ERVK-8 619465
Homo sapiens Primates protease PROTEASE ncbigene_synonym ERVK-10 100616101
Homo sapiens Primates protease PROTEASE ncbigene_synonym ERVK-9 100616102
Homo sapiens Primates protease PROTEASE ncbigene_synonym ERVK-21 100616103
Homo sapiens Primates protease PROTEASE ncbigene_synonym ERVK-18 100775105
Homo sapiens Primates protease PROTEASE ncbigene_synonym ERVK-25 100862683
Homo sapiens Primates protease PROTEASE ncbigene_synonym ERVK-24 100862684
Homo sapiens Primates protease PROTEASE ncbigene_synonym ERVK-19 105376906
Homo sapiens Primates Properdin PROPERDIN ncbigene_synonym CFP 5199
Homo sapiens Primates Kallikrein KALLIKREIN ncbigene_synonym KLK4 9622
Homo sapiens Primates APC3 APC3 ncbigene_synonym CDC27 996
Homo sapiens Primates C5L2 C5L2 ncbigene_synonym C5AR2 27202
Homo sapiens Primates MAC MAC famplex_relations C5 727
Homo sapiens Primates MAC MAC famplex_relations C6 729
Homo sapiens Primates MAC MAC famplex_relations C7 730
Homo sapiens Primates MAC MAC famplex_relations C8A 731
Homo sapiens Primates MAC MAC famplex_relations C8B 732
Homo sapiens Primates MAC MAC famplex_relations C8G 733
Homo sapiens Primates MAC MAC famplex_relations C9 735
Homo sapiens Primates APC5 APC5 ncbigene_synonym ANAPC5 51433
Homo sapiens Primates Cab CAB ncbigene_synonym CA1 759
Homo sapiens Primates Cab CAB ncbigene_synonym EIF6 3692
Homo sapiens Primates Cab CAB ncbigene_synonym NPDC1 56654
Homo sapiens Primates C5a C5A ncbigene_synonym C5AR1 728
Homo sapiens Primates Cir CIR ncbigene_synonym KCNJ5 3762
Homo sapiens Primates Cir CIR ncbigene_synonym CIR1 9541
Homo sapiens Primates Cir CIR ncbigene_synonym VIM2P 100130535
Homo sapiens Primates C1s C1S ncbigene_symbol C1S 716
Homo sapiens Primates C3a C3A ncbigene_synonym ERVK-2 100616100
Homo sapiens Primates C4BP C4BP ncbigene_synonym C4BPA 722
Homo sapiens Primates C4BP C4BP ncbigene_synonym C4BPB 725
Homo sapiens Primates CSAA CSAA ncbigene_synonym SAA4 6291
Homo sapiens Primates SMCP SMCP ncbigene_symbol SMCP 4184
Homo sapiens Primates DAF DAF ncbigene_synonym CD55 1604
Homo sapiens Primates CR1 CR1 ncbigene_symbol CR1 1378
Homo sapiens Primates CR1 CR1 ncbigene_synonym CRIPTO 6997
Homo sapiens Primates MCP MCP ncbigene_synonym CAPG 822
Homo sapiens Primates MCP MCP ncbigene_synonym CD46 4179
Homo sapiens Primates CD59 CD59 ncbigene_symbol CD59 966
Drosophila melanogaster Invertebrates AP AP ncbigene_symbol ap 35509
Drosophila melanogaster Invertebrates fB FB ncbigene_symbol fb 250310
Drosophila melanogaster Invertebrates fB FB ncbigene_synonym anon-16Fa 5657870
Drosophila melanogaster Invertebrates CP CP ncbigene_symbol cp 45277
Drosophila melanogaster Invertebrates Cr CR ncbigene_symbol CR 5657006
Drosophila melanogaster Invertebrates Ab AB ncbigene_symbol ab 34560
Drosophila melanogaster Invertebrates Ab AB ncbigene_synonym Appl 31002
Drosophila melanogaster Invertebrates MBL MBL ncbigene_symbol mbl 36945
Drosophila melanogaster Invertebrates APC3 APC3 ncbigene_synonym Cdc27 38798
Drosophila melanogaster Invertebrates MAC MAC ncbigene_synonym yip7 38680
Drosophila melanogaster Invertebrates MAC MAC ncbigene_synonym mAcon1 44149
Drosophila melanogaster Invertebrates APC5 APC5 ncbigene_synonym ida 45574
Drosophila melanogaster Invertebrates Cab CAB ncbigene_symbol Ca-beta 34557
Drosophila melanogaster Invertebrates Cab CAB ncbigene_symbol cab 45831
Drosophila melanogaster Invertebrates Cir CIR ncbigene_symbol Cir 5657832
Drosophila melanogaster Invertebrates Cir CIR ncbigene_synonym ci 43767
Drosophila melanogaster Invertebrates C3a C3A ncbigene_synonym mtSSB 41968
Drosophila melanogaster Invertebrates DAF DAF ncbigene_synonym nAChRalpha5 34826
Drosophila melanogaster Invertebrates MCP MCP ncbigene_synonym sls 44013
Drosophila melanogaster Invertebrates MCP MCP ncbigene_synonym Abd-B 47763

Chemical mentions

Word Match MeSH Name ChEBI
Mannose Mannose mesh:D008358 D-mannopyranose chebi:4208

Disease mentions

Word Match MeSH Name DOID